MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is introducing the world's first AI-powered voice analytics system to detect drug and alcohol impairment in real time, initially targeting the South American mining sector, where heavy machinery and remote operations make safety monitoring critical. The company, which has spent several years conducting research into intoxication detection, has developed a voice-based AI system designed to identify signs of alcohol or drug impairment within seconds, the first of its kind in the world.
Workplace substance misuse costs U.S. employers over $81 billion annually through lost productivity, accidents, healthcare costs, and liability, with studies indicating that up to 40% of industrial workplace fatalities involve alcohol misuse. Industrial employers across the world face a persistent challenge: ensuring workers operating heavy machinery or performing safety-critical tasks are not impaired by drugs or alcohol. Such advanced screening technology has relevance to a global market spanning a range of safety-sensitive industries, including mining, construction, and aviation.
Instead of relying on traditional biological samples, the new system uses artificial intelligence-driven speech analysis. The technology is more commonly associated with consumer devices than workplace safety, but MindBio is adapting it for industrial use. The platform is designed to provide rapid, non-invasive screening that can be deployed in remote or hazardous environments where traditional testing methods are impractical.
The announcement comes as companies seek innovative solutions to reduce workplace accidents and improve safety compliance. The mining sector, in particular, has been a focal point due to the high risk of operating heavy machinery in isolated locations. MindBio's initial rollout in South America targets this need, but the technology has broader applications across industries with similar safety requirements.
For more information, the latest news and updates relating to MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF.
MindBio Therapeutics is a biotechnology company focused on developing and commercializing innovative therapies and technologies. The company's voice-enabled AI platform represents a significant advancement in workplace safety technology, potentially reducing the economic and human costs of substance abuse in the workplace.
